Investigational New Drug (IND)  Current Federal law requires that a drug be the subject of an approved marketing application before it is transported or distributed across state lines. The IND is the means through which a sponsor technically obtains this exemption from the FDA and can conduct clinical studies to determine the safety and efficacy of the drug.